Skip to content

Imperial Prostate 8 - fluorescence confocal microscopy for rapid evaluation of surgical cancer excision

A multicentre blinded prospective cohort study to assess the accuracy of digital fluorescence confocal microscopy for assessment of surgical margins in radical prostatectomy specimens

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN21536411
Enrollment
155
Registered
2023-10-09
Start date
2023-08-17
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer Cancer

Interventions

Prostate specimens from subjects undergoing radical prostatectomy (RP) will be stained with a fluorescent dye (Histolog Dip) and then be scanned on a digital fluorescent confocal microscope (FCM) know

Sponsors

Imperial College Healthcare NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Men aged >/=18 years 2. Men undergoing radical prostatectomy at Imperial College Healthcare NHS Trust during the study period 3. Nerve sparing and non-nerve sparing radical prostatectomy cases

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 09/05/2024: 1. Men who do not consent for ex vivo tissue research 2. Men who are listed for salvage prostatectomy and had a previous prostate cancer treatment (radiotherapy, brachytherapy, focal therapy) _____ Previous exclusion criteria: 1. Men who do not consent for ex vivo tissue research through Imperial College Healthcare Tissue Bank (ICHTB) 2. Men who are listed for salvage prostatectomy and had a previous prostate cancer treatment (radiotherapy, brachytherapy, focal therapy) 3. Men enrolled in concurrent clinical trials requiring ex vivo prostatic tissue for research

Design outcomes

Primary

MeasureTime frame
Accuracy of digital FCM measured using the Histolog Scanner in detecting clinically significant prostate cancer at surgical margins at radical prostatectomy compared to traditional H&E histopathology (reference standard). Measures used to assess accuracy will be sensitivity, specificity, positive and negative predictive value. Clinically significant cancer is defines as Gleason score >/= 7 (ISUP Grade Group >/=2).

Secondary

MeasureTime frame
1. Sensitivity, specificity, positive and negative predictive value of digital FCM for detection of cancer at surgical margins, with traditional H&E histopathology as the reference standard, on a per-image/margin level 2. Area under the receiver operating characteristic curve (AUC) for cancer detection of digital FCM with traditional H&E histopathology as the reference standard 3. Agreement of digital FCM with the pathology report for cancer length at margin (mm) on a margin and patient level 4. Agreement of digital FCM with the pathology report for cancer grade at margin (mm) on a margin and patient level 5. Cohen’s kappa coefficient for agreement between readers (two individual histopathologists, histopathologist vs trainee histopathologist, histopathologist vs urologist)

Countries

England, United Kingdom

Contacts

Public ContactNikhil Mayor
n.mayor@imperial.ac.uk+44 (0)20 3313 1000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026